Poxel: Audience

Poxel is a clinical stage biopharmaceutical company focused on developing innovative treatments for chronic serious diseases with metabolic pathophysiology, particularly non-alcoholic steatohepatitis (NASH) and rare metabolic disorders. The company aims to provide safer and more effective therapies through its advanced pipeline of products.